Journal Article (382)
2007
Journal Article
28 (3), pp. 261 - 275 (2007)
Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system. Neurobiology of Disease
Journal Article
581 (29), pp. 5685 - 5690 (2007)
Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase. FEBS Letters
Journal Article
68 (12), pp. 958 - 959 (2007)
Multiple sclerosis: Relating MxA transcription to anti-interferon-β-neutralizing antibodies. Neurology
Journal Article
69 (21), pp. 1966 - 1967 (2007)
Revisiting the immunopathogenesis of the inflammatory myopathies. Neurology
Journal Article
68 (3), pp. 58 - 63 (2007)
Dual role of inflammation in CNS disease. Neurology
Journal Article
13 (5), pp. 462 - 467 (2007)
The prevalence of human herpesvirus 6 in human sensory ganglia and its co-occurrence with alpha-herpesvirus. Journal of Neurovirology
Journal Article
109 (10), pp. 4376 - 4382 (2007)
Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFα-dependent and Fc-receptor-independent way. Blood
Journal Article
68 (13), pp. 1076 - 1077 (2007)
NMO-IgG in the diagnosis of neuromyelitis optica. Neurology
Journal Article
5, pp. 2774 - 2783 (2007)
Revised diagnostic criteria for neuromyelitis optica-incorporation of NMO-IgG status. Nature Clinical Practise Neurology
Journal Article
66 (9), pp. 1266 - 1267 (2007)
The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis. Annals of the Rheumatic Diseases
Journal Article
130, pp. 2789 - 2799 (2007)
Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain
Journal Article
14 (26), pp. 2831 - 2838 (2007)
Synthetic peptides: The future of patient management in systemic rheumatic diseases? Current Medicinal Chemistry
Journal Article
5 (3), e39, pp. 616 - 628 (2007)
Absence of ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biology
Journal Article
85 (11), pp. 1161 - 1173 (2007)
Experimental models of spontaneous in the central nervous system. Journal of Molecular Medicine-JMM
Journal Article
64, pp. 1331 - 1333 (2007)
Delayed allergic reaction to natalizumab associated with early formation of neutralizing antibodies. Archives of Neurology
Journal Article
190 (1-2), pp. 72 - 79 (2007)
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. Journal of Neuroimmunology
Journal Article
36 (3), pp. 416 - 424 (2007)
Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice. Molecular and Cellular Neuroscience
Journal Article
68 (Suppl. 3), p. S1 - S1 (2007)
Neurodegeneration, neuroprotection, glial cells, and myelin in multiple sclerosis. Neurology
Journal Article
70 (4), pp. 693 - 695 (2007)
A DIGE-based approach to study interacting proteins. Journal of Biochemical and Biophysical Methods
Journal Article
204 (10), pp. 2363 - 2372 (2007)
Neurofascin as a novel target for autoantibody-mediated axonal injury. Journal of Experimental Medicine
Journal Article
104 (47), pp. 18625 - 18630 (2007)
Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
104 (3), pp. 920 - 925 (2007)
Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
4 (4), e133, pp. 0669 - 0674 (2007)
Antibody to aquaporin 4 in the diagnosis of neuomyelitis optica. PLoS Medicine
Journal Article
183 (1-2), pp. 220 - 224 (2007)
Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes. Journal of Neuroimmunology
Journal Article
4 (4), pp. 647 - 653 (2007)
Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics
Journal Article
330 (1), pp. 1 - 12 (2007)
L'énigme de l'entrée des lymphocytes T auto-immuns dans les tissus nerveux centraux et de leur attaque contre les structures de myéline. Comptes Rendus Biologies 2006
Journal Article
33 (4), pp. 462 - 476 (2006)
The role of neurotrophins in muscle under physiological and pathological conditions. Muscle & Nerve
Journal Article
131 (1-2), pp. 31 - 34 (2006)
Monoclonal antibodies improve therapy of relapsing multiple sclerosis. Molecular basis and clinical results of anti-VLA4 (natalizumab) therapy. Deutsche Medizinische Wochenschrift
Journal Article
6, pp. 663, 666, 670 - 664, 668 (2006)
Pregnancy and immunomodulatory therapy in multiple sclerosis patients. Nervenarzt
Journal Article
27, pp. S1 - S7 (2006)
The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis. Neurological Sciences
Journal Article
66 (3), pp. 153 - 159 (2006)
Production and applications of recombinant proteinase 3, Wegener's autoantigen: Problems and perspectives. Clinical Nephrology
Journal Article
149 (4), pp. 337 - 344 (2006)
Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives. British Journal of Pharmacology
Journal Article
116 (9), pp. 2385 - 2392 (2006)
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell B cell cooperation. The Journal of Clinical Investigation
Journal Article
129, pp. 200 - 211 (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain
Journal Article
18 (1), pp. 151 - 162 (2006)
Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP1-10 covalently bound to the MHC class II molecule I-A(u). International Immunology
Journal Article
22 (4), pp. 183 - 185 (2006)
Biomarkers in multiple sclerosis. Disease Markers
Journal Article
60 (4), p. 487 - 487 (2006)
B lineage cells in inflammatory central nervous system - Reply. Annals of Neurology
Journal Article
59 (6), pp. 880 - 892 (2006)
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation. Annals of Neurology
Journal Article
103 (32), pp. 12057 - 12062 (2006)
Reconstitution of paired T cell receptor α- and β-chains from microdissected single cells of human inflammatory tissues. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
3 (4), pp. 359 - 367 (2006)
Animal models of multiple sclerosis. Drug Discovery Today: Disease Models
Journal Article
36 (3), pp. 512 - 515 (2006)
Organ specific autoantigens and the autoreactive T cell repertoire: The case of myelin oligodendrocyte glycoprotein. European Journal of Immunology
Journal Article
10, pp. 1235 - 1245 (2006)
Revision of McDonald's new diagnostic criteria for multiple sclerosis. Nervenarzt 2005
Journal Article
17 (11), pp. 1419 - 1428 (2005)
Differential expression of the granzymes A, K and M and perforin in human peripheral blood lymphocytes. International Immunology
Journal Article
166 (5), pp. 1441 - 1450 (2005)
Complementary contribution of CD4 and CD8 T lymphocytes to T-cell infiltration of the intact and the degenerative spinal cord. American Journal of Pathology
Journal Article
252 (8), pp. 968 - 971 (2005)
Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. Journal of Neurology
Journal Article
57 (4), pp. 537 - 544 (2005)
Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations. Pediatric Research
Journal Article
159 (1-2), pp. 12 - 19 (2005)
Preferential expression and function of Toll-like receptor 3 in human astrocytes. Journal of Neuroimmunology
Journal Article
4 (9), pp. 567 - 575 (2005)
Glatiramer acetate in multiple sclerosis: Update on potential mechanisms of action. Lancet Neurology
Journal Article
1, pp. 34 - 44 (2005)
Drug insight: Using monoclonal antibodies to treat multiple sclerosis. Nature Clinical Practice Neurology
Journal Article
386 (1), pp. 61 - 67 (2005)
Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3. Biological Chemistry